Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund, Jonathan W. Cunningham, João Pedro Ferreira, Faı̈ez Zannad, Milton Packer, Gregg C. Fonarow, John J.V. McMurray, Scott D. Solomon
Topics & Concepts
MedicineHeart failureClinical endpointEjection fractionHazard ratioInternal medicineCardiologyCombination therapyRandomized controlled trialACE inhibitorPharmacologyAngiotensin-converting enzymeBlood pressureConfidence intervalHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and Management